Paul McBarron
2013
In 2013, Paul McBarron earned a total compensation of $743.7K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, and Secretary at Cyclacel Pharmaceuticals, a 76% increase compared to previous year.
Compensation breakdown
| Bonus | $128,744 |
|---|---|
| Option Awards | $258,161 |
| Salary | $334,398 |
| Other | $22,372 |
| Total | $743,675 |
McBarron received $334.4K in salary, accounting for 45% of the total pay in 2013.
McBarron also received $128.7K in bonus, $258.2K in option awards and $22.4K in other compensation.
Rankings
In 2013, Paul McBarron's compensation ranked 7,864th out of 12,286 executives tracked by ExecPay. In other words, McBarron earned more than 36.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,864 out of 12,286 | 36th |
Division Manufacturing | 2,844 out of 4,612 | 38th |
Major group Chemicals And Allied Products | 887 out of 1,466 | 40th |
Industry group Drugs | 672 out of 1,160 | 42nd |
Industry Pharmaceutical Preparations | 529 out of 890 | 41st |
Source: SEC filing on April 7, 2015.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2013.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020